Long-Term Guselkumab Persistence in Plaque Psoriasis

from TheBrief.Health · host TheBrief.Health

Study shows strong long-term guselkumab persistence in plaque psoriasis, unaffected by BMI or severity, while prior biologic—especially IL-17—use increases discontinuation risk.

Episode metadata supplied by the publisher feed · Published Dec 30, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Long-Term Guselkumab Persistence in Plaque Psoriasis

0:00 1:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on December 30, 2025.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!